Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial)

Written By RRCU Staff

Joselyn Rwebembera, MMed, Emma Ndagire, MMed, Natalie Carvalho, PhD, Allison R. Webel, PhD, Craig Sable, MD, Emmy Okello, PhD, Rachel Sarnacki, MBA, Alison M. Spaziani, MPH, Atukunda Mucunguzi, Msc, Daniel Engelman, PhD, Anneke Grobler, PhD, Andrew Steer, PhD, and Andrea Beaton, MD

American Heart Journal: Volume 275; 2024

RRCU Staff
Previous

Preintervention Wait Time and Survival in People With Rheumatic Heart Disease in Uganda
Next

Quality of Life in Ugandan Children and Young Adults After Surgery for Congenital Heart Disease: Mixed Methods Approach